Adverse Drug Reactions Monitoring
Patients with cardiovascular disease are particularly vulnerable to adverse drug reactions (ADRs). ADR occur frequently in modern medical practice, increasing mortality and morbidity and inflating the cost of care. Patients with cardiovascular disease are vulnerable due to their polypharmacy, advanced age, and the influence of heart disease on drug metabolism. The ADR potential for a particular cardiovascular drug varies the extent of exposure to other drugs, the disease being treated, and the individual.